Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25864
Abstract: Preoperative evaluation of resectable colorectal cancer liver metastases with positron emission tomography (PET) combined with computed tomography (PET‐CT) is used extensively. The PETCAM trial evaluated the effect of PET‐CT (intervention) vs no PET‐CT (control) on… read more here.
Keywords: pet; colorectal cancer; cancer liver; management ... See more keywords
Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26893
Abstract: Chemotherapy has been increasingly combined with surgery as multimodality treatment for resectable colorectal‐liver metastases (CLM). There is paucity of clinical data addressing optimal timing of chemotherapy relative to surgery. We examined outcomes of patients undergoing… read more here.
Keywords: liver; resectable colorectal; perioperative chemotherapy; colorectal liver ... See more keywords
Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores—— A retrospective, propensity score matching analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.973418
Abstract: Background The use of neoadjuvant chemotherapy (NAC) in resectable colorectal liver metastases (CRLM) patients is controversial. High-risk patients are more likely to benefit from NAC despite its hepatotoxic effects. Since patients with a high tumor… read more here.
Keywords: neoadjuvant chemotherapy; patients high; survival; resectable colorectal ... See more keywords